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Introduction
Stroke has been ranked among the most common causes of 
disability worldwide1,2 and is associated with a decrease in 
health-related quality of life (HRQOL).3–5 Traditionally, out-
come assessments in stroke rehabilitation have focused on 
improvement in symptoms and restoration of function, whereas 
patient-centred assessments, such as subjective well-being and 
HRQOL, are a more recent initiative.6 Patient-reported out-
comes (PRO) enhance our understanding of treatment out-
comes by indicating the impact of disease symptoms from the 
individual persons’ perspective.7 Of these measures, HRQOL 
has been recognized as increasingly important after stroke 
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because it improves our understanding of the impact of symp-
toms on persons’ lives and enables us to evaluate how treat-
ment affects persons’ functioning and well-being.7
Numerous generic and disease-specific scales that meas-
ure HRQOL after stroke are available. Generic instruments 
are frequently used to compare HRQOL outcomes across 
populations and diseases, while disease-specific instruments 
assess more nuanced states or concerns of specific diagnostic 
groups.8 A limitation of generic instruments is the lack of 
specificity regarding the quality of life-related consequences 
of a particular condition, such as stroke.9 Furthermore, they 
do not detect clinically relevant changes in HRQOL for a 
specific condition.10 The Stroke-Specific Quality of Life 
(SS-QOL) scale is a HRQOL measure that is specific and 
clinically relevant for assessing persons with stroke. The 
SS-QOL scale is a multidimensional PRO measure that 
assesses specific aspects of functioning and HRQOL issues 
relevant to ischaemic stroke survivors. As part of a current 
multicentre stroke study in Norway and Denmark, we 
decided to adapt the SS-QOL. However, although it has been 
validated and applied in Denmark, it has not been validated 
for use in Norwegian stroke survivors.
The original SS-QOL questionnaire measures 12 domains 
with 49 items. The domains and items were derived from 
interviews with stroke survivors in the United States.11 The 
SS-QOL scale has also been validated for persons with aneu-
rysmal subarachnoid haemorrhage.12,13 The validity of the 
SS-QOL scale has been examined in persons after stroke in 
various countries, for example, in Denmark with an ischae-
mic stroke population,14 Nigeria (Yoruba language),15 
Mexico,16 and Germany, where a short and long version for 
survivors of haemorrhagic or ischaemic stroke has been vali-
dated.17 A version with 8 instead of 12 factors was proposed 
that replicated the eight factors well. Hsueh et al.18 compared 
the construct validity of the 8- and 12-domain versions but 
favoured the latter, as it covered additional domains, thereby 
enhancing participants’ perspectives on HRQOL.
The objective of this study was to (1) translate and cross-
culturally adapt the 12-domain SS-QOL scale, version 2.0, 
into Norwegian for persons with ischaemic and haemor-
rhagic stroke; (2) examine the scale reliability (internal con-
sistency) and test–retest stability, and (3) assess aspects of 
the construct validity of the Norwegian scale.
Methods
Participants
This validation study was part of a multicentre cohort study, 
including persons 18 years or older with acute ischaemic 
(I63) or haemorrhagic stroke (I64). Persons with stroke 
admitted to one of the three stroke units at the University 
Hospital of North Norway who were living in the region 
were invited to participate. Stroke survivors excluded from 
the Norwegian National Stroke Register were also excluded 
from this study, for example, those with stroke related to 
brain malignancy, subarachnoid haemorrhage and/or trau-
matic brain injury (TBI).
From March 2014 through December 2014, this study 
prospectively included 125 participants who completed or 
nearly completed the SS-QOL questionnaire at 3 months 
after stroke. These participants accounted for 58% of the 214 
eligible stroke survivors during the defined recruiting period 
(Figure 1). The response rate was 78% (125 of 161 eligible), 
and among these, 41 participants (33%) received support 
filling out the forms. The size of the recruited sample was 
based on the sample size used in comparable published stud-
ies examining related research hypotheses.14
Table 1 shows the sociodemographic and stroke charac-
teristics of the 125 participants. The median age was 72 years 
(range 25–96 years). Over 90% lived in their homes at 
3 months, and 73% did not need any assistance.
Data collection procedures
Stroke survivors were informed about the study by nurses in 
the stroke units or by health professionals responsible for 
updating the information in the Norwegian National Stroke 
Register. Each hospital had one to three local health profes-
sionals who collected all the data and asked for participants’ 
written consent, which was obtained prior to commencing 
the study. A questionnaire package was mailed to the partici-
pants’ home address 3 months post stroke. Marital status, 
education and work status were collected from the question-
naires. Information on age, gender, living situation, stroke 
characteristics and modified Rankin Scale (mRS) was 
obtained from stroke registry data. The mRS is a scale that 
measures the degree of disability or dependence in activities 
of daily living (ADL).19 The scale ranges from 0 to 6 (‘per-
fect health to death’) and is widely used internationally 
throughout hospital services.
A sub-sample of 40 persons provided the consent to partici-
pate in a test–retest study at 12 months post-stroke onset, as 
stability in disease functioning and HRQOL scores may be 
presumed.20,21 Among the 40 recipients of the SS-QOL at 
12 months, 36 responded within the desired timeframe. We re-
administered the tool within 7 days from the date of the first 
administration. The COSMIN guidelines (consensus-based 
standards for the selection of health measurement instruments) 
were used as a checklist in the validation process.22
Predefined hypotheses
As suggested by Mokkink et al.,22,23 we predefined hypothe-
ses for the directions and magnitude of construct relation-
ships (i.e. correlation patterns and sizes) based on the 
available literature or, alternatively, a priori consensus discus-
sions between two of the authors (S.G.P and A.A.). Construct 
validity was considered supported if ≥75% of the results were 
in correspondence with these hypotheses.24 Convergent 
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validity was established by comparing the linear association 
of the individual domain score with the score of an estab-
lished outcome measure for that specific domain. None of the 
established measures covered the Vision and Language 
domains, and these domains were thus tested with single 
items from the Norwegian National Stroke Register. In the 
first three columns of Table 2, the domains and corresponding 
outcome measures (all previously validated in Norwegian), 
as well as the predefined hypotheses regarding construct rela-
tionships, are presented. We expected significant positive 
correlations between related HRQOL constructs. We expected 
negative correlations between the SS-QOL domain scores 
(i.e. Energy, Mood and Personality and total score) and 
measures of global psychological distress and depression 
(Hospital Anxiety and Depression Scale: total and depression 
score). No significant correlation was expected between the 
SS-QOL score and participants’ gender.
Measurements
Stroke-Specific Quality of Life (SS-QOL) scale, version 2.0, 
by Williams et al.11 consists of 49 items covering 12 domains: 
Mobility, Energy, Upper Extremity Function, Work and 
Productivity, Mood, Self-Care, Social Roles, Family Roles, 
Vision, Language, Thinking and Personality. Each domain is 
measured by three to six items using a 5-point (1–5) Likert 
Figure 1. Flowchart of persons with acute ischaemic or haemorrhagic stroke registred in the county of Troms in Norway during the 
recruiting period.
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scale (higher scores indicate better function). An average 
non-weighted raw score for each domain can be generated. 
The overall SS-QOL summary score is most often used as 
the primary outcome, although the separate domain scores 
are helpful for identifying specific areas that are affected by 
stroke or that improve the most or least over time.11 The 
validity of the SS-QOL has been examined when adminis-
tered by telephone,25,26 self-report and mail14 and with proxy 
responders.17,27
The Quality of Life After Brain Injury, Overall Scale 
(QOLIBRI-OS) is a brief HRQOL index originally constructed 
as a self-report scale for persons with TBI.28 The QOLIBRI-OS 
measures six functional areas using single-item questions 
assessing the following: (1) physical condition, (2) cognition, 
(3) emotions, (4) function in daily life, (5) personal and social 
life and (6) current situation and future prospects. Each item is 
scored from 1 (‘not at all’) to 5 (‘very’), and the sum score is 
arithmetically converted to a percentage score from 0 to 100 
(worst–best).28 The QOLIBRI-OS has demonstrated good 
validity and reliability in persons with TBI29 and subarachnoid 
haemorrhage30 and was recently validated for use in persons 
with stroke.
The EuroQol Quality of Life Scale-5D (EQ-5D) is a 
generic HRQOL measure that evaluates five dimensions: 
mobility, self-care, ADL, pain, and anxiety/depression. 
Self-ratings were categorized into three groups in relation to 
possible levels of problems (1 = no, 2 = mild/moderate, and 
3 = severe).31 It is possible to assign health-state utility indi-
ces based on different value sets, although according to the 
literature,32,33 construct validation should be performed on 
descriptions of the five dimensions and not the preference-
based index that can be derived from the measure. In this 
study, we used individual dimensions to test the construct 
validity. The total score was used to test the convergent 
validity of the total SS-QOL scale. The EQ-5D has been 
evaluated extensively in different cultures and languages, 
and it was designed to be self-administered and quick enough 
to complement other quality of life measures.31
EuroQol Visual Analogue Scale (EQ VAS) is the second 
part of the EQ-5D questionnaire. The participants rate their 
state of health by drawing a line from a box marked ‘Your 
health state today’ to a point on the VAS scale, which ranges 
from 0 to 100 (worst to best imaginable health).31
Hospital Anxiety and Depression Scale (HADS) consists 
of 14 items that assess non-vegetative symptoms of depres-
sion (7 items) and anxiety (7 items). It can be used to reliably 
and validly detect these two mental health states.34 The HADS 
has been used as a screening tool in several languages and is 
particularly suited for hospital populations,35 including per-
sons with stroke.36 It uses a response scale of 0–3 (higher is 
Table 1. Sociodemographic and stroke characteristics.
Responders (N = 125)
Age at the time of injury, mean (SD) 70.5 (13.1)
Gender, n (%)
 Female 48 (38)
 Male 77 (62)
Stroke subtype, n (%)
 Ischaemic 113 (90)
 Haemorrhagic 12 (10)
Marital status, n (%)
 Married/cohabitant 80 (64)
 Widowed/single 45 (36)
Education, n (%)
 ≤10 years 60 (48)
 >10 62 (50)
 Unknown 3 (2)
Living conditions at 3 months, n (%)
 Home, without assistance 92 (73)
 Home, with assistance 23 (19)
 Institution/residence for elderly 10 (8)
Work status at 3 months, n (%)
 Student/unemployed/working fulltime or part-time 23 (18)
 Retired/sick-leave 102 (82)
Modified Rankin Scale at 3 months, n (%)
 0–1 no symptoms or no significant disability 84 (67)
 2–3 slight or moderate disability 33 (26)
 4–5 severe disability 8 (7)
SD: standard deviation.
Pedersen et al. 5
worse). Subscale sum scores range from 0 to 21,34 and a cut-
off score ≥8 has been used to indicate a potential diagnosis of 
depression37 in Norwegian samples. The total HADS score 
(range 0–42) can additionally be considered a global measure 
of psychological and emotional distress.38
Stroke registry data. To test convergent validity, responses to 
the ADL questions ‘Mobility’ and ‘Getting dressed’ from the 
Norwegian National Stroke Register were used, as well as 
‘Problems with vision’ and ‘Problems speaking’ (not present 
prior to stroke).
Translation and cross-cultural adaptation
The translation process followed standard guidelines, which 
included forward–backward translation, expert validation 
and field testing.39 Three bilingual translators conducted 
independent forward translations from English to Norwegian. 
A multidisciplinary, bilingual committee of four health pro-
fessionals, all with a neurological background and special 
competence in stroke, prepared a reconciled Norwegian lan-
guage version from the translations. The committee also 
reviewed the introductory statements and the instructions for 
the questionnaire. Three independent, bilingual health pro-
fessionals performed the back translations from the 
Norwegian to the English version. Disagreements were 
resolved through discussion, and the discrepancies resulted 
in small changes to the Norwegian version, explained below.
In the English version, the response categories for the 
domains Mobility, Upper Extremity Function, Self-Care, 
Vision, Language and Work/Productivity were ‘Couldn’t do it 
at all’, ‘A lot of trouble’, ‘Some trouble’, ‘A little trouble’ and 
‘No trouble at all’. In Norwegian, trouble and difficulty have 
the same meaning, but difficulty is more commonly used. This 
modification was made based on the different back translations 
generated. As in the Danish version,14 the response category 
Table 2. Construct validity of the SS-QOL scale domains: Results of hypotheses testing in 125 participants 3 months post stroke.
SS-QOL domain Measure Correlation hypothesis Spearman’s ρ
Mobility N-NSR item ‘Mobility’ Low to moderate 0.47
 EQ-5D domain ‘Gait’ Moderate to high 0.63
Energy HADs total score Moderate to high (negative) −0.65
 EQ-5D: EQ VAS scale Moderate to high 0.48
Upper extremity function N-NSR self-care ‘Getting dressed’ Low to moderate 0.47
 EQ-5D domain ‘Usual activities’ Moderate 0.62
Work/productivity EQ-5D domain ‘Usual activities’ Moderate to high 0.73
Mood HADs depression Moderate (negative) −0.65
Self-care QOLIBRI-OS item ‘Daily activities’ Moderate to high 0.54
 EQ-5D domain ‘Personal hygiene’ Moderate to high 0.68
Social roles QOLIBRI-OS item  
 ‘Personal and social life’ Moderate to high 0.56
 QOLIBRI-OS total score Moderate 0.62
Family roles QOLIBRI-OS item  
 ‘Personal and social life’ Moderate to high 0.58
 QOLIBRI-OS total score Moderate 0.64
Vision N-NSR item ‘problems with vision 
not present prior to stroke’
Moderate 0.25
Language N-NSR item ‘Problems speaking 
not present prior to stroke’
Moderate 0.42
Thinking QOLIBRI-OS item  
 ‘Concentrate/remember/thinking’ High 0.65
 QOLIBRI-OS total score Moderate 0.64
Personality QOLIBRI-OS item  
 ‘Feelings/emotional state’ Moderate to high 0.48
 HADs Depression Low to moderate (negative) −0.52
SS-QOL total QOLIBRI-OS total score Moderate to high 0.71
 EQ-5D total score Moderate 0.73
 HADs total Moderate to high (negative) −0.69
 Gender No correlation −0.17
N-NSR: Norwegian–National Stroke Register at 3 months. Single-item questions (n = 112–114). EQ-5D: The EuroQol Quality of Life Scale-5D; HADs: 
Hospital Anxiety and Depression Scale; QOLIBRI-OS: The Quality of Life After Brain Injury, Overall Scale; SS-QOL: Stroke-Specific Quality of Life scale 
(n = 125)
Correlation coefficients: ±0.1 small; ±0.3 medium; ±0.5 large.
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for ‘personality’ in the additional psychometric section of the 
questionnaire was altered to obtain a more appropriate response 
in Norwegian. Explanatory examples within the items were 
excluded in the Norwegian version. To ensure that the transla-
tion was fully comprehensible, four participants admitted to a 
stroke unit were asked to complete the questionnaire and pro-
vide feedback if they found any item, response category or 
instruction unclear or misleading.
Statistical analyses
All analyses were conducted in SPSS 23. The distributional 
properties of the subscales were examined visually and para-
metrically (e.g. kurtosis and skewness). The descriptive data 
were presented as the means, standard deviations (SDs) and 
ranges or as proportions. Chi-square (or Fisher’s exact) tests 
were used to compare categorical data, whereas independ-
ent-sample t-tests were used to compare the mean differ-
ences between two groups. Non-normally distributed data 
were examined with non-parametric statistical analyses (e.g. 
Mann–Whitney test). Occasionally missing items were 
replaced with the mean of the subscale if less than three 
items were missing. The internal consistency of the SS-QOL 
total and domain scores were examined by calculating 
Cronbach’s alpha values (higher than 0.7 are preferable).40
Floor and ceiling effects were calculated as the percent-
age of participants with the minimum or maximum score in 
each domain. Floor and ceiling frequencies higher than 15% 
were considered substantial.24 Item-total correlations within 
the range of 0.4–0.9 were considered acceptable.41 Test–
retest stability was examined by two means: (1) Spearman’s 
ρ, to quantify the magnitude of the relationship between the 
scores on the first and second administration, which should 
preferably surpass 0.7,24,40 and (2) intra-class correlation 
coefficients (ICCs), to assess stability in the use of the 
response scale by comparing the consistency with absolute 
agreement estimates. The ICC should also surpass 0.7.24 A 
distribution-based method was used to calculate the standard 
error of measurement (SEM). The formula was based on 
Cronbach’s alpha and the SD.42
Data quality
All primary missing data were recorded and summarized for 
each item in the SS-QOL questionnaire. Missing data were 
collected from participants by telephone when possible, and 
when not, the mean of the domain score was used as a 
replacement when only one or two items were missing from 
the total scale. SS-QOL questionnaires with more than two 
missing were not included in the study.
Ethics
This study was conducted according to the Helsinki 
Declaration regarding informed consent and confidentiality. 
The Regional Norwegian Ethical Committee Health Region 
North approved the study (2013/1461).
Results
Translation
The forward- and back-translation process confirmed a sat-
isfactory match in semantic meaning between the original 
and the back-translated SS-QOL items. The few exceptions 
were resolved through consensus discussion, which resulted 
in removing explanatory examples and revising the layout, 
for example.
Missing data
The degree of missing data in the SS-QOL was very low 
(1.4%), and these data were replaced by consulting the par-
ticipants or using the domain mean (Table 3). The most fre-
quently missing item was ‘I had sex less often than I would 
like’, which was in the Social roles domain.
Ceiling effects
The SS-QOL total score had an acceptably low ceiling 
effect (8.8%), whereas all the domain scores had ceiling 
effects surpassing the 15% limit (Table 3). The domains 
Self-Care, Vision and Language had considerable ceiling 
effects (above 50%). Conversely, floor effects were pre-
dominantly absent.
Reliability
The domains of the SS-QOL scale showed acceptable and 
good internal consistency, with Cronbach’s alpha coeffi-
cients ranging from 0.79 to 0.93. The alpha value for the 
SS-QOL total score was 0.97. The item-total correlations 
ranged between 0.44 and 0.83 for all 49 items.
In all, 36 participants returned the retest, enabling an 
examination of the measurement stability. The test–retest 
stability was generally good, as Spearman’s correlations 
were all high (Table 3), except for in three domains with 
coefficients below 0.7 (Thinking (ρ = 0.65), Energy 
(ρ = 0.66) and Vision (ρ = 0.35)). The ICC values were 
excellent for all domains. The differences between the 
consistency and the absolute agreement-based ICC esti-
mates were minor, thus indicating that participants inter-
preted the response scale similarly at both measurement 
occasions.
SEM
The SEMs are presented in Table 4 and indicate the small-
est degree of change in the total or domain score that 
reflects a true change in the construct, that is, not con-
founded by measurement error. A change score of at least 
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one SEM represents the smallest margin that can indicate 
a minimally clinically important difference.42 As expected, 
the minimally required change scores were higher for the 
domain scores than the SS-QOL total score. These values 
that can be used as guidance in studies investigate change 
over time.
Construct validity
The correlations between the SS-QOL scale and the crite-
rion-related measures are presented in Table 2, as are the 
hypothesized directions and magnitudes. As many measure-
ments had ordinal scales and a few criterion-related variables 
were based on a single item, an ordinal correlation metric 
was preferred. All observed coefficients corresponded with 
the hypothesized correlations.
Discussion
This study examined the psychometric properties of the 
Norwegian version of the SS-QOL scale. The reliability, in 
terms of consistency and test–retest stability, was good. The 
construct validity was also supported, as the SS-QOL total 
and domain scores correlated as expected with the criterion-
related measures.
Validity
The COSMIN panel defines validity as ‘the degree to which 
an instrument truly measures the construct it purports to 
measure’.43 Validity is a broad concept that can be distin-
guished into content, criterion and construct validity in the 
context of questionnaire validation.41 Determining the con-
tent validity of the SS-QOL involved a subjective critical 
evaluation of whether the SS-QOL items reflected a repre-
sentative selection of indicators measuring the intended con-
cept. The content validity of the SS-QOL has been well 
documented by others11 and was not re-evaluated here. 
Rather, we focused on the construct, or more specifically, the 
criterion validity of the SS-QOL by examining whether it 
was positively correlated with the EQ-5D sum score, spe-
cific EQ-5D domains, EQ VAS and QOLIBRI-OS as 
expected (convergent validity) and negatively correlated 
with the HADS total score and HADS depression score 
(divergent validity).41
Convergent and divergent validity. The SS-QOL scale is a com-
prehensive measurement, and as recommended in the COS-
MIN guidelines,22 we hypothesized the magnitudes and 









Mean (SD) Internal 
consistency 
Cronbach’s α
Floor and ceiling 
effects (%)
Test–retest reliability (N = 36)
Spearman’s ρ p
Mobility 6 2 4.28 (0.92) 0.93 0.8 36.0 0.84 <0.001




5 0.5 4.28 (1.04) 0.93 1.6 43.7 0.94 <0.001
Work and 
Productivity
3 1 4.21 (1.07) 0.92 3.2 47.6 0.94 <0.001
Mood 5 2 3.93 (1.05) 0.84 1.6 27.8 0.84 <0.001
Self-care 5 0 4.46 (0.93) 0.92 2.4 54.8 0.89 <0.001
Social roles 5 3 3.29 (1.30) 0.91 7.1 15.9 0.80 <0.001
Family roles 3 2 3.96 (1.19) 0.83 2.4 38.9 0.79 <0.001
Vision 3 0 4.58 (0.75) 0.79 1.6 62.7 0.35 <0.05
Language 5 0.3 4.59 (0.70) 0.91 0.8 56.3 0.74 <0.001
Thinking 3 2 3.79 (1.19) 0.83 3.2 32.5 0.65 <0.001
Personality 3 2 3.99 (1.18) 0.87 2.4 41.3 0.83 <0.001
SS-QOL 
total
49 1.4 4.09 (0.80) 0.97 0.8 8.8 0.89 <0.001
Table 4. Standard error of measurement (SEM).
Mobility 0.24
Energy 0.41
Upper extremity function 0.27
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directions of the correlations for all the specific domains and 
for the total SS-QOL scale against related measurements. The 
Vision domain had a lower correlation than estimated, whereas 
all other correlations were as expected or higher than expected, 
supporting the construct validity of the questionnaire (Table 2).
Reliability
Internal consistency. The reliability, or internal consistency, of 
the domain and total SS-QOL scores were high. The degree of 
consistency reported in this study was comparable and slightly 
higher than that reported by Williams et al.,11 Muus et al.,14 
and Hsueh et al.18 Of the 12 domains, 7 had alpha values 
>0.90. The observed differences were most likely related to 
variances in sample size and sampling procedures. Our study 
included more participants than the study by Williams et al.,11 
for example, and likely a more heterogeneously composed 
sample than those of the abovementioned studies. Most of the 
participants had mild- or moderate-severity stroke, similar to 
corresponding studies.11,14 However, our study did not exclude 
persons with more severe stroke, with aphasia and/or cogni-
tive problems or with comorbidities. Our more heterogeneous 
sample may partly explain the higher alpha values.41 Accord-
ing to de Vet et al.,41 Cronbach’s alpha values above 0.90 may 
indicate redundancy of items and suggest the need to shorten 
the scale. However, since the domains of the SS-QOL scale 
consist of three to six items, we would not recommend this 
approach.
Test–retest reliability. The test–retest reliability of the SS-
QOL was satisfactory, with only three domains showing val-
ues below 0.7 (Table 3). Other SS-QOL validation studies 
using the same test–retest timeframe (1–2 weeks) displayed 
correlations from 0.71 to 0.9616 and 0.65 to 0.99.14 The 
Vision domain was again problematic, showing the lowest 
test–retest correlation with Spearman’s rho of 0.35 (p < 0.05). 
One of the items ‘Did you have trouble reaching for things 
because of poor eyesight?’ might have been ambiguous to 
the participants, as it may convey two meanings: physical 
problems with reaching for items independent or dependent 
of eyesight. ‘Trouble reaching for things’ after a stroke can 
be related to sensory motor deficits or other perceptual and 
cognitive impairments such as apraxia, agnosia, neglect or 
other visuospatial challenges. It may be difficult for persons 
with stroke to establish the reason why they are experiencing 
difficulties. As some of the included participants reported 
vision problems, this health problem should not be over-
looked, and a future approach may be to improve the clarity 
of this question. The psychometric properties of the Vision 
domain were not satisfactory, and we suggest rephrasing at 
least one of the three items and then re-validating the domain.
The Energy and Thinking domains also had test–retest 
coefficients below 0.7, which may reflect a true day-to-day 
fluctuation (e.g. the need to rest, various levels of ability to 
concentrate) rather than an unreliable domain, as Cronbach’s 
alpha values were satisfactory. The high reliability and the 
low SEM scores in several of the domains in our study, all 
below 0.5 SD, indicate that the SS-QOL scale is highly suit-
able for assessing individual participants’ HRQOL, as well 
as in researching HRQOL among stroke survivors.
Quality of data. The data quality in this study was good, with 
a low amount of missing data. As noted by others, for exam-
ple, Muus et al.,14 the item ‘I had sex less often than I would 
like’ (Social Roles domain) had the largest number of miss-
ing responses (15%, n = 19). This item might be considered 
less relevant or too sensitive or private for some of the par-
ticipants. Another item, ‘change in personality’ (prior to 
stroke), was also often incomplete. Personality changes can 
be difficult to assess by the individuals themselves, or the 
question might be too sensitive to answer. Another possibil-
ity, also noted by Muus et al.,14 is that the layout of the ques-
tionnaire, with this particular item separated from the others, 
could make it easier to overlook. Overall, the high data qual-
ity indicated that the SS-QOL questionnaire was understand-
able and easy to complete.
Floor/ceiling effects. Less than 9% of the total SS-QOL scores 
exceeded the ceiling threshold, which may be considered 
acceptably low. The ceiling effects of the domain scores 
were higher but on par with previous findings,11,14,18 ranging 
from moderate to high. A ceiling effect was particularly pre-
sent for the Vision domain (62.7%), as Muus et al.14 also 
reported. The variations in ceiling effects reflected areas that 
were more or less affected by stroke. The observed ceiling 
effect in the Vision, Language and Self-Care domains may 
indicate that these areas are less frequently affected among 
the responders in this stroke population.
As persons with stroke are a heterogeneous group with 
various and different degrees of symptoms, some degree of 
ceiling (or floor) effects is expected. These effects may be 
problematic because they weaken the ability to distinguish 
participants in the higher (ceiling) or lower (floor) levels of 
the construct, whereas the middle area is less affected. 
However, a high score within an SS-QOL domain simply 
reflects normal functioning within this area, and according to 
de Vet et al.,41 when a large proportion of the population has 
no functional problems, it should not be considered a ceiling 
effect. In contrast, a lower score may indicate a particular 
functional problem within a domain. Due to the considerable 
heterogeneity in the symptoms and functional consequences 
of stroke, ceiling (or floor) effects are normally more present 
in domain scores than the total score, and thus, the total score 
is more suitable for measuring changes in the follow-up 
period than the domain scores.
Limitations and strengths of the study
As reported in previous studies,11,14 most of the respondents 
had mild to moderate stroke. Although some eligible stroke 
Pedersen et al. 9
survivors were lost due to administrative errors, we consider 
the study population reasonably representative for measur-
ing HRQOL following stroke.
The convergent and discriminant validity, as indicators of 
construct validity, is a strength of the study, which tested prede-
fined hypothesis and expected associations among similar and 
dissimilar measures as recommended in the literature.40,41 For 
two domains in our study, the only available option was to cor-
relate the SS-QOL domain with a single-item question from 
the Norwegian National Stroke Register. It could be argued 
that these questions are not as valid as a validated question-
naire, though the directions of the correlations were as expected 
in these occasions as well. Our choice of measurements did 
consider respondent burden, and we thus chose measurements 
that were practical, not too extensive, and appropriate for 
HRQOL assessment post stroke in this population.
Examining the discriminative validity of the SS-QOL 
using factor analytic methods was not deemed appropriate in 
this study due to the low subject-to-item ratio. The large 
number of items and particularly the large number of latent 
factors (12 domains) would require a considerably larger 
sample size to achieve satisfactory statistical power.44 Due to 
the low power in this study to test such complex models, the 
risk of type II error would be unduly high. The 12-domain 
factor structure has previously been examined using con-
firmatory factor analysis in a sample of 388 stroke survivors, 
and the results supported the current factor model.18
Conclusion
The Norwegian version of the SS-QOL scale is an instru-
ment with good psychometric properties. It is suited for use 
in health research as well as in individual assessments of per-
sons with stroke.
Clinical messages
• Our results support the Norwegian version of the SS-QOL 
scale as an instrument with good psychometric properties.
• Construct validity of the scale is well supported.
• The instrument is applicable, understandable and easy to 
complete. 
• The SS-QOL scale is suited for use in research as well as 
in assessments of individual stroke survivors.
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